Skip to main content
Log in

Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Intramuscular injections of botulinum toxin type A (BTX-A) have increasingly been used to reduce spasticity in specific muscle groups in children with cerebral palsy. Targets of therapeutic efforts are improvement of gross motor function, alleviation of pain or facilitation of hygienic care. Placebo-controlled studies have shown the local and functional effectiveness of BTX-A for the treatment of dynamic pes equinus. Whether long-term treatment with BTX-A improves motor development and delays contractures is still under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirschner, J., Berweck, S., Mall, V. et al. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option. J Neurol 248 (Suppl 1), I28–I30 (2001). https://doi.org/10.1007/PL00007815

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007815

Navigation